These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N. Lancet; ; 366(9486):649-59. PubMed ID: 16112301 [Abstract] [Full Text] [Related]
25. N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies. Wu K, Wang X, Xie Z, Liu Z, Lu Y. J Int Med Res; 2013 Feb; 41(1):31-7. PubMed ID: 23569127 [Abstract] [Full Text] [Related]
26. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Wang YH, Yeh SD, Shen KH, Shen CH, Juang GD, Hsu LI, Chiou HY, Chen CJ. Toxicol Appl Pharmacol; 2009 Nov 15; 241(1):111-8. PubMed ID: 19686770 [Abstract] [Full Text] [Related]
28. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J. Cancer Epidemiol Biomarkers Prev; 2006 Jan 15; 15(1):99-107. PubMed ID: 16434594 [Abstract] [Full Text] [Related]
32. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. Wang YH, Yeh SD, Wu MM, Liu CT, Shen CH, Shen KH, Pu YS, Hsu LI, Chiou HY, Chen CJ. J Hazard Mater; 2013 Nov 15; 262():1139-46. PubMed ID: 23009795 [Abstract] [Full Text] [Related]
33. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Cancer Res; 1994 Aug 01; 54(15):4103-11. PubMed ID: 8033143 [Abstract] [Full Text] [Related]
34. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F, Hou SM, Hemminki K, Lambert B, Pershagen G. Cancer Epidemiol Biomarkers Prev; 1998 Oct 01; 7(10):875-83. PubMed ID: 9796632 [Abstract] [Full Text] [Related]
36. GSTP1 gene Ile105Val polymorphism causes an elevated risk for bladder carcinogenesis in smokers. Pandith AA, Lateef A, Shahnawaz S, Hussain A, Malla TM, Azad N, Shehjar F, Salim M, Shah ZA. Asian Pac J Cancer Prev; 2013 Oct 01; 14(11):6375-8. PubMed ID: 24377535 [Abstract] [Full Text] [Related]
38. NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis. Dhaini HR, El Hafi B, Khamis AM. Drug Metab Rev; 2018 May 01; 50(2):208-219. PubMed ID: 29258340 [Abstract] [Full Text] [Related]
40. A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey. Yaris F, Dikici MF, Sabuncu HH, Yaris E. Asian Pac J Cancer Prev; 2006 May 01; 7(4):591-4. PubMed ID: 17250433 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]